Your browser doesn't support javascript.
loading
Systemic Light Chain Amyloidosis, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology.
Kumar, Shaji K; Callander, Natalie S; Adekola, Kehinde; Anderson, Larry D; Baljevic, Muhamed; Campagnaro, Erica; Castillo, Jorge J; Costello, Caitlin; D'Angelo, Christopher; Devarakonda, Srinivas; Elsedawy, Noura; Garfall, Alfred; Godby, Kelly; Hillengass, Jens; Holmberg, Leona; Htut, Myo; Huff, Carol Ann; Hultcrantz, Malin; Kang, Yubin; Larson, Sarah; Lee, Hans C; Liedtke, Michaela; Martin, Thomas; Omel, James; Rosenberg, Aaron; Sborov, Douglas; Valent, Jason; Berardi, Ryan; Kumar, Rashmi.
Afiliação
  • Kumar SK; Mayo Clinic Cancer Center.
  • Callander NS; University of Wisconsin Carbone Cancer Center.
  • Adekola K; Robert H. Lurie Comprehensive Cancer Center of Northwestern University.
  • Anderson LD; UT Southwestern Simmons Comprehensive Cancer Center.
  • Baljevic M; Vanderbilt-Ingram Cancer Center.
  • Campagnaro E; University of Michigan Rogel Cancer Center.
  • Castillo JJ; Dana-Farber/Brigham and Women's Cancer Center | Massachusetts General Hospital Cancer Center.
  • Costello C; UC San Diego Moores Cancer Center.
  • D'Angelo C; Fred & Pamela Buffett Cancer Center.
  • Devarakonda S; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute.
  • Elsedawy N; St. Jude Children's Research Hospital/The University of Tennessee Health Science Center.
  • Garfall A; Abramson Cancer Center at the University of Pennsylvania.
  • Godby K; O'Neal Comprehensive Cancer Center at UAB.
  • Hillengass J; Roswell Park Comprehensive Cancer Center.
  • Holmberg L; Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance.
  • Htut M; City of Hope National Medical Center.
  • Huff CA; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.
  • Hultcrantz M; Memorial Sloan Kettering Cancer Center.
  • Kang Y; Duke Cancer Institute.
  • Larson S; UCLA Jonsson Comprehensive Cancer Center.
  • Lee HC; The University of Texas MD Anderson Cancer Center.
  • Liedtke M; Stanford Cancer Institute.
  • Martin T; UCSF Helen Diller Family Comprehensive Cancer Center.
  • Omel J; Patient advocate.
  • Rosenberg A; UC Davis Comprehensive Cancer Center.
  • Sborov D; Huntsman Cancer Institute at the University of Utah.
  • Valent J; Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute.
  • Berardi R; National Comprehensive Cancer Network.
  • Kumar R; National Comprehensive Cancer Network.
J Natl Compr Canc Netw ; 21(1): 67-81, 2023 01.
Article em En | MEDLINE | ID: mdl-36652935
ABSTRACT
Primary systemic light chain amyloidosis (SLCA) is characterized by production of light chains that get converted to amyloid fibrils with an affinity for visceral organs and causing organ dysfunction. The therapy for SLCA is directed to recovering the function of the affected organs by targeting the abnormal plasma cell clone and slowing deposition of amyloid fibrils. The NCCN Guidelines for SLCA provide recommendations for workup, diagnosis, and treatment of primary as well as previously treated SLCA.
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Assunto principal: Amiloide / Amiloidose Tipo de estudo: Diagnostic_studies / Etiology_studies / Guideline Limite: Humans Idioma: En Revista: J Natl Compr Canc Netw Assunto da revista: NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Assunto principal: Amiloide / Amiloidose Tipo de estudo: Diagnostic_studies / Etiology_studies / Guideline Limite: Humans Idioma: En Revista: J Natl Compr Canc Netw Assunto da revista: NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article